Veterinary medicines have been recognised by the Government as critical to human and animal welfare and national security.
The majority of veterinary medicines used in the UK (and ingredients and components to make them) are either produced in or enter via the EU. The Government is working with animal health companies who have been carrying out extensive EU Exit contingency planning for all EU Exit scenarios, including no deal, covering all aspects of their supply chains, from regulatory compliance and stocking levels to logistics and customs. This includes, as appropriate, increasing stocks of product in the UK, changing supply routes, transferring marketing authorisations and other regulatory processes.
Additional cross-government activities include a comprehensive business/trader readiness information campaign to help individuals and businesses understand what they need to do to get ready for Brexit and the Government’s Freight Capacity Framework is intended to support the continued supply of Category 1 goods (to include veterinary medicines) in the event of border disruption.
Supply is expected to cope with a normalised ordering pattern.
With this planning in place, we are confident that we have made every effort to ensure continuity of supply of veterinary medicines in the UK.